跳至主要内容
临床试验/KCT0004516
KCT0004516尚未招募未知

A multicenter clinical trial to evaluate the efficacy, safety and usability of cyclosporine ophthalmic nanoemulsion 0.05% compared with cyclosporine ophthalmic emulsion 0.1%

Kangbuk Samsung Medical Center0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • 1) Adult men and women over the age of 19
  • 2) KCDSG guidelines diagnosed with dry eyes with moderate or higher levels
  • (1) Cornea dye score NEI = 3 points or
  • (2) TBUT =10 sec
  • 3) Patients who can be monitored for at least 3 months
  • 4) Those who understand this clinical trial and voluntarily agree to it in writing

排除标准

  • 1) In case ophthalmic cyclosporin preparation is used by the person currently in use or within the last month
  • 2) Persons with active eye infection such as Stevens-Johnson syndrome
  • 3) A person with a past history of corneal transplantation or neuronutitis
  • 4) Those with eye failure or condition that may affect the analysis of the research result, or those with history
  • phobiasis, conjunctival scarring caused by semisplastic cornea, sclerosis, lack of serous tear glands, conjunctivitis, corneal esophageal force, etc.
  • 5) Those who are overreacting to the ingredients (cyclosporin) of the clinical trial
  • 6) Pregnant or nursing mothers

研究者

相似试验